Literature DB >> 16738855

Clinicopathological findings of retinal angiomatous proliferation.

Hiroyuki Shimada1, Akiyuki Kawamura, Ryuzaburo Mori, Mitsuko Yuzawa.   

Abstract

BACKGROUND: Neovascular membranes obtained from surgical excision of neovascularization for retinal angiomatous proliferation (RAP) were examined histopathologically in an attempt to elucidate the pathogenic mechanism of RAP.
METHODS: Nine eyes of eight patients (mean age, 79 +/- 6 years) who underwent neovascularization excision were studied. Three eyes had stage II with RPE detachment, six had stage III. Immunohistochemical studies were performed to identify von Willebrand factor, vascular endothelial factor (VEGF), CD68 and hypoxia inducible factors (HIF-1 alpha and HIF-2 alpha).
RESULTS: Multiple soft drusen were present in the macular area in all patients. In one stage II eye, we observed intraretinal neovascularization as a VEGF-positive mass, CD68-positive macrophage migration and HIF expression. In another stage II eye, neovascularization had extended above the RPE, while VEGF-positive fibroblasts were observed below the RPE. Therefore, in stage II, neither angiographic nor histopathological examinations identified choroidal neovascularization. In one phase III eye, angiography demonstrated choroidal neovascularization and chorioretinal anastomosis. Histopathologically, chorio-retinal communication was observed in the region where the RPE was destroyed, and VEGF-positive neovascularization was also seen below the RPE.
CONCLUSIONS: The findings of multiple drusen in elderly patients together with macrophage migration and HIF expression surrounding VEGF-positive retinal neovascularization suggest ischemic and inflammatory factors to be associated with the development and progression of RAP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16738855     DOI: 10.1007/s00417-006-0367-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  10 in total

Review 1.  Continuing medical education review: choroidal neovascularization in age-related macular degeneration--what is the cause?

Authors:  Richard F Spaide; Donald Armstrong; Richard Browne
Journal:  Retina       Date:  2003-10       Impact factor: 4.256

2.  Retinal angiomatous proliferation in age-related macular degeneration.

Authors:  L A Yannuzzi; S Negrão; T Iida; C Carvalho; H Rodriguez-Coleman; J Slakter; K B Freund; J Sorenson; D Orlock; N Borodoker
Journal:  Retina       Date:  2001       Impact factor: 4.256

3.  Surgical excision of neovascularization in retinal angiomatous proliferation.

Authors:  Hiroyuki Shimada; Ryuzaburo Mori; Keiko Arai; Akiyuki Kawamura; Mitsuko Yuzawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

4.  Foveolar choroidal blood flow in age-related macular degeneration.

Authors:  J E Grunwald; S M Hariprasad; J DuPont; M G Maguire; S L Fine; A J Brucker; A M Maguire; A C Ho
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-02       Impact factor: 4.799

5.  Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration.

Authors:  B A Lafaut; S Aisenbrey; C Vanden Broecke; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

6.  Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.

Authors:  Jeffrey L Edelman; David Lutz; Marisol R Castro
Journal:  Exp Eye Res       Date:  2005-02       Impact factor: 3.467

7.  Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization.

Authors:  A Kvanta; W Y Shen; S Sarman; S Seregard; B Steen; E Rakoczy
Journal:  Curr Eye Res       Date:  2000-09       Impact factor: 2.424

8.  Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging.

Authors:  R S Ramrattan; T L van der Schaft; C M Mooy; W C de Bruijn; P G Mulder; P T de Jong
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-05       Impact factor: 4.799

9.  Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis.

Authors:  J Donald M Gass; Anita Agarwal; Adrian M Lavina; Khaled A Tawansy
Journal:  Retina       Date:  2003-12       Impact factor: 4.256

10.  Hypoxic regulation of vascular endothelial growth factor in retinal cells.

Authors:  L P Aiello; J M Northrup; B A Keyt; H Takagi; M A Iwamoto
Journal:  Arch Ophthalmol       Date:  1995-12
  10 in total
  16 in total

1.  High resolution Fourier-domain optical coherence tomography of retinal angiomatous proliferation.

Authors:  Steven N Truong; Suhail Alam; Robert J Zawadzki; Stacey S Choi; David G Telander; Susanna S Park; John S Werner; Lawrence S Morse
Journal:  Retina       Date:  2007-09       Impact factor: 4.256

2.  Retinal and choroidal vascular changes in coronary heart disease: an optical coherence tomography angiography study.

Authors:  J Wang; J Jiang; Y Zhang; Y W Qian; J F Zhang; Z L Wang
Journal:  Biomed Opt Express       Date:  2019-03-04       Impact factor: 3.732

3.  Expression of hypoxia-inducible factor-1alpha and -2alpha in human choroidal neovascular membranes.

Authors:  Carl M Sheridan; Stephanie Pate; Paul Hiscott; David Wong; David M Pattwell; David Kent
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-10       Impact factor: 3.117

4.  Retinal oxygen saturation, vessel diameter and flicker response in eyes with specific subtypes of neovascular age-related macular degeneration during aflibercept treatment.

Authors:  Stefan Sacu; Katharina Eibenberger; Doreen Schmidl; Sandra Rezar-Dreindl; Gerhard Garhöfer; Jonas Brugger; Wolf Buehl; Leopold Schmetterer; Ursula Schmidt-Erfurth
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

5.  Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP).

Authors:  Lazaros Konstantinidis; Evangelia Mameletzi; Irmela Mantel; Jean-Antoine Pournaras; Leonidas Zografos; Aude Ambresin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-04-29       Impact factor: 3.117

6.  Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization.

Authors:  Mingkai Lin; Yang Hu; Ying Chen; Kevin K Zhou; Ji Jin; Meili Zhu; Yun-Zheng Le; Jian Ge; Jian-Xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-14       Impact factor: 4.799

7.  Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation.

Authors:  Tarek S Hemeida; Pearse A Keane; Laurie Dustin; Srinivas R Sadda; Amani A Fawzi
Journal:  Br J Ophthalmol       Date:  2009-10-23       Impact factor: 4.638

8.  Choroidal circulatory disturbances associated with retinal angiomatous proliferation on indocyanine green angiography.

Authors:  Hideki Koizumi; Tomohiro Iida; Masaaki Saito; Dai Nagayama; Ichiro Maruko
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-31       Impact factor: 3.117

9.  Characterization of a spontaneous retinal neovascular mouse model.

Authors:  Eiichi Hasegawa; Harry Sweigard; Deeba Husain; Ana M Olivares; Bo Chang; Kaylee E Smith; Amy E Birsner; Robert J D'Amato; Norman A Michaud; Yinan Han; Demetrios G Vavvas; Joan W Miller; Neena B Haider; Kip M Connor
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

10.  One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages.

Authors:  Young Gun Park; Young-Jung Roh
Journal:  BMC Ophthalmol       Date:  2015-12-21       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.